The The demand for COVID-19 treatments has created a demand for meta-analyses by systematic review — a process fraught with risk, as evidenced by questionable studies on Ivermectin, write scientists in Nature Medicine. Jack Lawrence, Gideon Meyerowitz-Katz, James Heathers, Nicholas Brown and Kyle Sheldrick explain why they feel so strongly about this controversial medication as … Continue reading Ivermectin papers show limitations of ‘inherently unreliable’ summary data